Axogen Inc. (AXGN) Fundamentals

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically proven and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, United Kingdom, Spain, South Korea, and several other countries.
SHARE INFORMATION
Market Cap$ 424,528,499
Shares Outstanding42,283,715
Float35,058,803
Percent Float82.91%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 127,358,000
Latest Fiscal EPS$ -0.64
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment CashCash
HOLDERS
Institutions330
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months2,706,262
Institutional Holdings Percent121.9%
Institutional Sold Previous 3 Months2,528,595
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months346,058
Insider Holdings Percent9.3
Insider Sold Previous 3 Months165,067
Insider Shares Owned3,894,685
TRADING INFO
52 Week High$ 17.99
52 Week Low$ 6.87
52 Week High Change$ -36.66
21 Day Moving Average$ 9.5533
21 Day Extended Moving Average$ 9.6652
50 Day Moving Average$ 9.1226
50 Day Extended Moving Average$ 9.2725
200 Day Moving Average$ 9.2811
200 Day Extended Moving Average$ 10.1756
10 Day Average Volume214,175
20 Day Average Volume210,334
30 Day Average Volume186,370
50 Day Average Volume217,129
Alpha-0.003927
Beta0.8221
Standard Deviation0.160018
R20.066025
7 Day Price Change$ -0.45
7 Day Percent Change-4.29%
21 Day Price Change$ 0.59
21 Day Percent Change6.24%
30 Day Price Change$ 1.90
30 Day Percent Change23.34%
Month to Date Price Change$ 0.72
Month to Date Percent Change7.73%
Quarter to Date Price Change$ 1.85
Quarter to Date Percent Change22.59%
180 Day Price Change$ 1.79
180 Day Percent Change21.7%
200 Day Price Change$ 1.76
200 Day Percent Change21.26%
Year to Date Price Change$ 0.67
Year to Date Percent Change7.15%

Axogen Inc. (AXGN) Key Ratios

PROFITABILITY
EBIT Margin-23.9%
EBITDA Margin-20.3%
Pre-Tax Profit Margin-21.8%
Profit Margin Count-24.69%
Gross Margin82.5%
Profit Margin TOT-24.69%
INCOME STATEMENTS
Revenue$ 128,202,000
Revenue Per Share$ 3.0319
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book4.30
Total Debt To Equity0.70
Int Coverage-32.30
Current Ratio4.50
Leverage Ratio1.90
Quick Ratio3.30
Long Term Debt To Capital0.39
VALUATION MEASURES
PE Ratio-13.50
Enterprise Value$ 432,485,150
Price to Sales3.3114
Price to Free Cash-9.30
PE High Last 5 Years-24.90
Price To Book4.20
Price To Cash Flow0.00
PE Low Last 5 Years-55.10
Price to Tangible Book4.30
MANAGEMENT EFFECTIVENESS
Receivables Turnover6.90
Invoice Turnover1.40
Assets Turnover0.70
Return Assets-16.56
Return on Equity-30.63
Return on Capital-17.23

Axogen Inc. (AXGN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorDeloitte & Touche LLP
CEOKaren Zaderej
Emplyoees451
Last AuditUQ
CIK0000805928
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing(334510)
CONTACT INFO
Address13631 Progress Boulevard
Suite 400
Alachua, FL 32615
Websitehttps://www.axogeninc.com
Facsimile+1 386 462-6801
Telephone+1 386 462-6800
EmailInvestorRelations@AxoGenInc.com


Your Recent History
NASDAQ
AXGN
Axogen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.